The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Having said that, My view is that they are a nanocap company, with limited no of staff and I expect that the number of commercial collaborators they are speaking to is Small. Having said that if my presumption that the collaborator they refer to is Medimmune, the research arm of a 70 billion pound company I would be more than pleased
Hopefully the current and upcoming results will allow them to play bigger venues than Mello derby. A japan tour would be good- the rns feedback following the last trip was that it provided useful introductions which would be progressed and they provided them with a 3 month supply of nuvec. News of upcoming presentations/ trips seem to boost the share price more than the actual positive results themselves. I expect a drip of conference dates to be announced now with associated videos of NT
Vander, would you of thought the Japan visit should have attracted some interest? I questioned Nigel about this months ago and his reply was “these things take time” which is understanding but that was back in February.
The UoA results shouldn’t be too far off if N4 decides to publish the efficacy results at the initial trial period or wait until immunogenicity works are finalised which is months away. I guess this depends on Medlmmune or Astra for that matter! It’s anyone’s guess at this stage.
Mazik- you are correct to say that my perspective is too narrow
The last nuvec results were presented in this poster:
https://www.n4pharma.com/sites/default/files/documents/vaccine-conference-poster.pdf
Some nice pictures to illustrate the results They brought this to Amsterdam and japan I presume
They have removed it from the n4p website in readiness for the next lot of results
The next bit is NT promoting the results to potential suitors
Multiple commercial deals are anticipated during first half of 2019 as per September RNS ...a lot is happening as per today' Nuvec update..IMO
An important aspect of today is that the commercial collaborations being progressed are most likely with Medimmune. A deal at this point would be too early. Nuvec needs more development to be a trial ready product. It is in both parties interest that further studies will take until first half of 2019. What do others think?
O/T bob good luck, in my opinion frr and ars still weak..ATM
Very quick one going out for fun n frolics.
maz, FRR say no more.
p.s lol
Bob good night, its unreal to see day traders selling at loss. Yes we will see it going further north this week..imo
Car or wife? ..lets see its early days :-)
Not sure if the Banger is the Wife or the Car Maz ?? Lol
Have a great evening all.
More Blue Tomorrow fingers crossed.
Comp off and a glass of Red.
Night All
Bob hah! hah! hope so, then i replace my banger
Just hoping we can raise steadily and under the radar. Mazik I must say you’ve been impressively brave, patienct and politely composed..You’ll hopefully see a very healthy return in not so many months!
Maz never be afraid off double digits my friend.
You will be a nervous wreck come an honest pound lol
All the best
Leister followed suit today with a topup this morning and last thursday, i am afraid we will soon see double figures...
Small top up for me... We’ll have plenty more when your ready Nigel 😉
Charty i have Never in my years heard of a new grip on shares !?
But i like it Sir, Lets get Grippy.
gla
Right now N4P is building new grip. Expect these to cut through 6.85 - 7.15 one of these days, which would then lead to a substantial upleg in my opinion.
Wow, very nice spread now!
Can someone make a test buy for 100k?
Next buy signal in my opinion when 6.50p are climbed.
Vander, you hit the nail on the head. The platform could yield many opportunities. We have the platform, we just need to see how many uses it has. So far from being "one trick"
It’s a single pony with multiple tricks ie a platform FWIW I think it will now prove positive in all the small animal research ie phase 1 UoA should pass ok. The immune response should be ok in mice. A challenge will be the large animals and what conditions it is used for. A key result is income. This does need a finished product but a collaboration to produce a trial ready product with CTA authorisation to enter human trials They now will have a collaboration with Medimmune for up to 18 months and Eu ncl characterisation with access to people who understand what the regulatory body ie EMEA need for nanoparticles in which the rules are still being written This is all in my opinion/my prediction Interesting times
At least he can lick his Boolacks though.
Poor Terrier, nothing like putting yourself down lol
Binary play... To be fair, newbie buyers should notice that N4P has become a pure binary play! The company now only has one shot in the pipeline left: Nuvec. Nothing else. -------- "The Sp will soon dive down to 4p and stay there terminal." Terrier54 "N4p has become a pure binary play, thats why I jumped ship and sold at 4.80p." Several posters on Lse.uk
Nice to see us holding up in a depressed market.
N4P looking good to show us the considerable prize with a dollop of luck of course.
Feeling quite moist after this news.
Nice top ups/entries for those below the 5ps .
She moves very quickly on a bit of positivity.
The odds are well on our side, huge gains or sheeze n bust.
Take your positions this train could leave you behind with a sideways swoop of news.
gla
Very confident for N4P future as per today's RNS "We are building a compelling data package to aide our commercial collaboaration discussions which we continue to progress." Expecting more announcements in November..IMO
6.00 is sexy. Let's keep it here please.